Abstract
Background Resistance to epidermal growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitors (TKIs) is a pervasive bar......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
